MONDAY, Sept. 30, 2019 -- A drug that targets faulty gene repair may buy more time for some men with advanced prostate cancer, a new clinical trial finds.
Experts called the study "landmark," because it zeroed in on men with particular gene mutations that can be targeted with newer drug therapies. It's an approach that is already used in treating breast, ovarian and lung cancers.
FRIDAY, Oct. 11, 2019 -- Taking opioids after a vasectomy doesn't improve pain control and is associated with increased risk of persistent use of the addictive painkillers months later, a new study says.
It included 228 men who had vasectomies performed by eight different urologists. Two of the urologists routinely prescribed opioids for pain after the surgery. The other six used other methods to control pain -- over-the-counter medications (acetaminophen and ibuprofen), scrotal support and ice.
TUESDAY, Sept. 17, 2019 -- In what might be a major breakthrough, researchers report that high doses of radiation dramatically prolonged survival in men battling an advanced and aggressive form of prostate cancer.
This particular type of cancer occurs when tumors resurface and spread to a number of areas beyond the prostate among patients who were in remission following radiation, surgery or chemotherapy. Generally, the outlook for the patient at this point is grim, the researchers noted.
TUESDAY, Sept. 17, 2019 -- Running contrary to current guidelines, new research suggests that use of hormone-suppressing treatment over the long term may not help some men battling recurrent prostate cancer, and may even cause harm.
In fact, the study found that long-term hormone therapy was tied to a raised risk of death from other causes for some patients who received it.